19 HARTUM STREET, BYNET BUILDING, 3RD FL, Jerusalem, L3
Material disclosure
Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder
Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives
Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting
Announces Minority-Stake Investment in Hopemark Health
From an Innovative Technology to a Fast - Growing ARR Company Investor Deck | May 2026
Reports First Quarter 2026 Financial Results and Operational Highlights
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Notice of Exempt Offering of Securities
No filings found
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
S-8 POS
Correspondence
Submission Upload